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Abstract
In this work we introduce the concept of correlation chemical shift imaging (CCSI). Novel CCSI
pulse sequences are demonstrated on clinical scanners for two-dimensional COSY (Correlation
Spectroscopy) and TOCSY (Total Correlation Spectroscopy) imaging experiments. To date there
has been limited progress reported towards a feasible and robust multivoxel 2D COSY. Localized
2D TOCSY imaging is shown first time in this work. Excitation with adiabatic GOIA-W(16,4)
pulses (Gradient Offset Independent Adiabaticity Wurst modulation) provides minimal chemical
shift displacement error, reduced lipid contamination from subcutaneous fat, uniform optimal flip
angles, and efficient mixing for coupled spins, while enabling short repetition times due to low
power requirements. Constant-density spiral readout trajectories are used to acquire
simultaneously two spatial dimensions and f2 frequency dimension in (kx,ky,t2) space in order to
speed up data collection, while f1 frequency dimension is encoded by consecutive time increments
of t1 in (kx,ky,t1,t2) space. The efficient spiral sampling of the k-space enables the acquisition of a
single-slice 2D COSY dataset with an 8×8 matrix in 8:32 min on 3T clinical scanners, which
makes it feasible for in-vivo studies on human subjects. Here we present the first results obtained
on phantoms, human volunteers and patients with brain tumors. The patient data obtained by us
represent the first clinical demonstration of a feasible and robust multivoxel 2D COSY. Compared
to the 2D J-resolved method, 2D COSY and TOCSY provide increased spectral dispersion which
scales up with increasing main magnetic field strength and may have improved ability to
unambiguously identify overlapping metabolites. It is expected that the new developments
presented in this work will facilitate in-vivo application of 2D chemical shift correlation MRS in
basic science and clinical studies.
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1. INTRODUCTION
Spectrally two-dimensional (2D) chemical shift correlation MR spectroscopy (MRS)
methods, such as COSY (Correlation Spectroscopy, (1)) or TOCSY (Total Correlation
Spectroscopy, (2)) can help to unambiguously identify overlapping metabolites. Currently,
in-vivo 1D MRS includes contribution from 18 metabolites (3), however ex-vivo 2D MRS
on intact tissue biopsies (4,5) distinguish more than 30 metabolites. Besides resolving
overlapping peaks such as lactate / lipids, glutamate / glutamine / GABA, and total choline
(Choline / Phosphocholine / Glycerophosphocholine), in-vivo 2D COSY or TOCSY could
identify new metabolites of interest in normal physiology and disease.
Scalar coupled spins are allowed to exchange magnetization during a so called mixing
period in COSY and TOCSY experiments. While for COSY (1) the mixing happens during
the t1 evolution which is free of RF pulses, for TOCSY (2) the mixing period is realized
under the action of a train of RF pulses right after t1 evolution. The train of RF pulses in
TOCSY is used to average out the chemical shift interaction and create an average
Hamiltonian that contains only the isotropic scalar coupling interaction. Hence, spins can
exchange magnetization over multiple bonds in TOCSY (6), while in COSY (7) only direct
scalar coupled spins exchange magnetization. This is achieved at the cost of increased RF
power deposition in TOCSY. For assignment purposes in homonuclear spin systems,
TOCSY experiment is one of the most powerful methods because: i) it obtains the full
correlation matrix (direct and relay crosspeaks) of the spin network, while COSY provides
only direct correlations; and ii) pure absorptive phase-sensitive crosspeaks are obtained in
TOCSY, while COSY exhibits crosspeak multiplets with equal positive and negative
intensities leading to zero integrated intensity in phase-sensitive spectra, or to partial signal
cancellation and increased linewidths in magnitude mode spectra. In particular the last
aspects could be important for in-vivo applications. Compared to 2D J-resolved spectra (8)
that resolve overlapped signals along a second and fixed scalar coupling dimension (limited
to ±15 Hz for 1H), 2D COSY and TOCSY provide increased spectral dispersion along a
second larger chemical shift dimension which scales up to kHz with increasing main
magnetic field strength, B0.
To date, most in-vivo localized 2D COSY data have been recorded as single voxel (L-COSY
(9), CT-COSY (10)), and there is limited progress reported towards a feasible multivoxel
implementation (11–17). In-vivo 1D spectral-editing TOCSY has been shown previously
(18,19), and localized 2D TOCSY (20) was recently demonstrated, but only as single-voxel
methods. However, single-voxel techniques represent a serious limitation, and expanding the
spatial coverage is highly desirable for clinical applications, as a control voxel in a healthy
area is often needed in addition to the voxel in pathological region of interest. Due to
inherently long acquisition times of 2D COSY or TOCSY, their multivoxel implementation
is difficult to realize within feasible limits of in-vivo scan times using conventional phase
encoding (11,12). Hadamard spectroscopy (14), ultrafast low-angle rapid acquisition with
relaxation enhancement (15), multiple spin-echoes (16) and EPI (13,17) acquisitions have
been proposed to shorten scan time of multivoxel COSY (named correlation peak imaging in
Ref. (11)). In particular, spectroscopic methods using multiple spin-echoes (21,22) and
PEPSI (23,24) acquire simultaneously one spatial dimension and one frequency dimension.
However, scan times of multivoxel 2D COSY based on these methods are still too long (25–
30 min for brain) for many clinical applications.
In this work we propose the broader concept of correlation chemical shift imaging (CCSI)
which includes both 2D COSY and 2D TOCSY imaging experiments. We show that CCSI
can be performed in-vivo by robust experiments in feasible amounts of time on human brain.
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Compared to previous approaches of multivoxel COSY (11–17), our method uses an
improved adiabatic localization and a time efficient spiral spatial encoding.
We used low power optimized adiabatic sequences to excite the signal in COSY and
TOCSY experiments. These are based on 2D COSY-LASER and Z-TOCSY-LASER pulse
sequences that were previously demonstrated in single voxel experiments (20). Here we
extended their use for the purpose of CCSI. We make use of constant-density spiral
trajectories that simultaneously encode two spatial dimensions and one frequency
dimension. The spiral sampling of k-space in spectroscopic imaging (25–28) has been
shown previously to make feasible the acquisition of multivoxel 2D J-resolved (29,30), and
CT-PRESS homonuclear decoupled (31) spectra on human subjects.
2D-spectral/2D-spatial data obtained on 3T and 1.5T clinical scanners for phantoms, healthy
volunteers and patients with brain tumors are presented. In particular, adiabatic 2D COSY
spiral imaging at 3T can be obtained in 8:32 min with adequate signal to noise ratio (SNR)
in human brain scans for a single slice of 8×8 matrix, 2×2 cm2 in plane resolution, 2.5 cm
slice thickness, and 10 ml voxel volume. In-vivo adiabatic 2D TOCSY spiral imaging is
demonstrated on healthy volunteers at 1.5T using the same acquisition matrix and voxel
size. Data obtained by us on volunteers and phantoms represent the first example of TOCSY
imaging, while patient data represent the first clinical demonstration of a feasible and robust
multivoxel 2D COSY.
2. THEORY
In CSI experiments pre-selection of a large volume of interest (VOI) is obtained using slice
selective pulses which are applied in three orthogonal directions, such as in the case of
PRESS (32), STEAM (33) and LASER (34) sequences. Constant adiabaticity gradient
modulated GOIA-W(16,4) pulses (35) and LASER are optimal for selection of VOI by
providing: 1) precise localization with negligible chemical shift displacement error (CSDE),
uniform flip angle excitation of VOI, and no lipid contamination from subcutaneous fat; 2)
efficient mixing for scalar coupled spins over a large bandwidth (BW); and 3) reduced
power deposition or specific absorption rate (SAR).
CSDE is inversely proportional with BW of slice selective pulse (CSDE ~1/BW), thus
increasing pulse BW is effective in reducing CSDE. For conventional pulses BW is limited
by the maximum B1 available, however, adiabatic pulses can obtain very large BW when B1
is limited. GOIA-W(16,4) pulses (35) can achieve 20 kHz bandwidth with 0.81 kHz (18.7
µT) maximum B1 field. With a BW of 20 kHz a negligible 2% CSDE is obtained over 3.5
ppm 1H chemical shift range at 3T. By comparison, Mao refocusing pulses (36) that are
typically used in L-COSY (9) can have up to 38% CSDE over a 3.5 ppm 1H chemical shift
range at 3T (35). By design, GOIA pulses (37) also have the advantage of a constant
adiabatic factor over entire BW, while for conventional adiabatic pulses the adiabatic factor
decreases away from center frequency. In addition to minimizing CSDE, GOIA-W(16,4)
pulses provide optimal flip angles uniformly across large VOI and spectral bandwidth (SW),
which is especially important for enabling efficient coherence transfer among scalar coupled
spins. A comparison between VOI localized with LASER, PRESS, L-COSY and STEAM is
included in Supplementary Information (Fig. S1).
In 2D COSY-LASER (Fig. 1) sequence GOIA-W(16,4) pulses are used only for
localization. For 2D Z-TOCSY-LASER (Fig. 1) sequence GOIA-W(16,4) pulses are used
for magnetization transfer between scalar coupled spins during MLEV-16 mixing block, and
for localization within LASER block. Low SAR of GOIA-W(16,4) allows short repetition
times (TR) for 2D COSY-LASER (TR = 1s at 3T) and Z-TOCSY-LASER (TR = 2s-3s at
3T) sequences (20). Details of the 2D-spectral/2D-spatial CCSI pulse sequences (COSY-
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LASER-SPIRAL and TOCSY-LASER-SPIRAL) are given in the Figure 1 and in the
Methods section.
In particular, adiabatic longitudinal mixing for TOCSY has been shown by quantum
mechanical simulations and experiments (20) to be more efficient than adiabatic transverse
mixing (19). The Hamiltonian of TOCSY mixing under MLEV-16 scheme (38) using
GOIAW(16,4) pulses in the case of a two scalar coupled spins is given by
[1]
assuming Np (multiple of 16) gradient modulated adiabatic pulses with B1,k(t) amplitude
modulation, φk(t) phase modulation, Gk(t) gradient modulation , and Ωn (n = 1,2)
and J represent chemical shifts and scalar coupling, respectively (in frequency units), Îα,n(α
= x,y,z; n = 1,2) denote individual spin operators, and F̂α (α = x,y,z) total spin system
operators (F̂α = Îα,1 + Îα,2). The Hamiltonian of COSY can be obtained simply from Eq. [1]
by removing the RF term. In the case of most mobile metabolites the influence of
anisotropic interactions such as chemical shielding anisotropy and dipolar couplings on
coherent evolution of the spin system can be neglected.
RF pulses with a constant adiabatic factor (Q) can be obtained if modulation functions fulfill
the condition (37,39)
[2]
, where ωc is the center sweep frequency and φk(0) represents the initial phase of the pulse,
which in our case follows MLEV-16 scheme (i.e. φk(0) = 0 if k = 1,2,5,8,11,12,14,15 and
φk(0) = π if k = 3,4,6,7,9,10,13,16). The B1(t) and G(t) modulations are defined in (37) and
are based on WURST function (40).
The coherent spin evolution under the Hamiltonian of Eq. [1] is determined by Liouville-
von-Neumann equation of motion for spin density matrix (41)
[3]
, which has formal solution
[4]
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, with propagator , and T is the Dyson time-ordering operator. In
the case of time periodic perturbations such as MLEV-16, the propagator over a full period
of mixing time (tmix) can be expanded by Average Hamiltonians Theory (AHT, (42)) into a
series
[5]
where the first order average Hamiltonian  is consider to have the most
important contribution, and higher order terms are often included only as corrections. The
aim of MLEV-16 scheme is to remove the influence of chemical shift and create an average
Hamitonian that in the first order contains only scalar coupling interaction . The
amplitude of the RF field needs to exceed a certain threshold to obtain this ideal average
Hamiltonian. In practice, for RF fields that are feasible in-vivo on humans a somewhat
weaker average Hamiltonian is obtained  with a smaller effective scalar
coupling constant Jeff ≤ J. We have shown this effect through numerical simulations of
TOCSY buildups (Fig. 2A,B).
TOCSY crosspeaks buildup curves can be simulated assuming that initially only one of the
spins has magnetization (i.e. initial density matrix σ̂(0) = Îz,1 for longitudinal mixing) and
detecting magnetization transferred on the second spin (〈Îz,2〉 = Tr{σ ̂(tmix)Îz,2}) for
increasing mixing times (tmix). In practice numerical integration of Eq. [4] offers an easier
approach than analytical tools, such as Average Hamiltonian Theory (42) or Floquet Theory
(43), that are needed for solving Eqs. [3–4] with a time dependent Hamiltonian. Buildup
curves at 1.5T and 3T under MLEV-16 with GOIA-W(16,4) pulses of 2ms and 1.5ms
durations are shown in Figure 2 for the case of a lactate spin system. Incoherent relaxation
mechanisms were not included explicitly in these buildups.
COSY buildups can be simulated similarly by considering σ̂(0) = Îx,1 and 〈Îx,2〉 = Tr{σ ̂
(tmix)Îx,2}, under the time constant Hamiltonian that contains only chemical shift and scalar
coupling interactions. COSY buildup curves at 1.5T and 3T were simulated by omitting RF
part from Hamiltonian of Eq. [1].
Spiral spectroscopic imaging (25,26) trades off spatial resolution with spectral bandwidth.
Given spatial resolution requirements and physical limitations of gradient hardware on
clinical scanners it is impossible to encode all spatial information with a spiral trajectory of
length less than, or equal to Δt2 (0.833 ms for SW of 1.2 kHz). Hence, interleaved spiral
trajectories (Ninterleaves = Na * Nt) are necessary, which typically are decomposed into so-
called angular (Na) and temporal (Nt) interleaves. The desired field of view (FOV), spatial
resolution (matrix size) and SW are obtained by modifying the duration of each spiral lobe
concomitant with the number of angular interleaves (for FOV, spatial resolution) and the
number of temporal interleaves (for SW). Angular interleaving decompose the (kx,ky) space
into sparser Na spiral trajectories rotated by . For temporal
interleaving, the readout gradients start (n − 1)Δt2 seconds  later relative to the
ADC acquisition. The choice of temporal or angular interleaves is made such that
acquisition time (Na*Nt*TR) is minimized. A rewinder gradient is used after each spiral
gradient to return to the origin of k-space, the duration of the rewinder being fixed to the
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shortest value. In order to estimate spatial encoding of spiral trajectories, simulations of
point spread function (PSF) were performed and are shown in Figure 3.
3. METHODS
3.1. Numerical simulations
Quantum mechanical simulations were performed in GAMMA (44) for buildup curves of
crosspeaks under TOCSY mixing with MLEV-16 and GOIA-W(16,4) pulses, and for COSY
omitting RF part from the Hamiltonian of Eq. [1]. A two spin system was considered to have
lactate’s chemical shifts and scalar coupling (Ω1 = 1.3 ppm, Ω2 = 4.1 ppm, J = 6.93 Hz from
Ref. (45)). Buildup curves were simulated for two main magnetic fields B0 at 1.5T and 3T,
which are clinically the most common. Typically, the maximum possible RF amplitude
(γB1,max) does not exceed 1kHz for body coils on clinical scanners. Hence, for TOCSY we
investigated two GOIAW(16,4) pulses designed to have the minimum (R = 20) adiabatic
factor and specific absorption rate (SAR) for in-vivo use: i) duration Tp = 2 ms, bandwidth
BW = 10 kHz, γB1,max = 0.76 kHz, and ii) Tp = 1.5 ms, BW = 13.34 kHz, γB1,max = 1.02
kHz. These buildups were compared with the ideal buildup when chemical shifts are
neglected and only scalar coupling is considered. In all simulations spin evolution was
calculated using a piece-wise constant Hamiltonian with a time step of 20 µs, as detailed in
Ref. (20). Symmetry of pulse shapes and periodicity in spin evolution were exploited to
speed-up calculations.
Point spread functions were simulated in Matlab (The MathWorks, Inc., Natick, MA, USA)
for constant density spiral trajectories that were used to acquire FOV = 160×160 mm2 and
SW = 1.2 kHz with two matrix sizes of 8×8 and 16×16, respectively. The spiral gradient
waveforms that were generated on the scanner during sequence preparation were exported
and numerically integrated. Hardware infidelities and possible experimental deviations from
theoretical gradient waveforms were not taken into account.
3.2. Hardware and sequence programming
All measurements were done on 3T Tim Trio or 1.5T Avanto systems (Siemens, Erlangen,
Germany), using body coil for transmission and a 32-channel head phased receive array. The
maximum amplitude of B1 field delivered by the transmit body coil is limited to 1 kHz (23.4
µT). The gradient system specifications include a maximum nominal amplitude of 26 mT/m
and a maximum slew rate of 170 mT/(m·ms).
For both COSY and TOCSY experiments VOI was selected along three orthogonal spatial
dimensions with a symmetric LASER localization employing GOIA-W(16,4) pulses (35)
with duration of 3.5 ms, BW of 20 kHz, and B1,max of 0.817 kHz. Gradient spoilers of 10
mT/m and 8 mT/m, 1.58 ms total duration (540 µs ramp-up/down times, 500 µs flat top)
were placed around slice selective pulses on all gradient channels. The minimum LASER
echo time (TE) that can be obtained with these parameters is 40 ms. Amplitude, gradient and
phase modulations of GOIA-W(16,4) were implemented in the scanner sequence software
(VB17A) according to Ref. (35).
TOCSY mixing was performed with GOIA-W(16,4) pulses of 2 ms, 10 kHz BW and 0.76
kHz B1,max following an MLEV-16 scheme (20). To enable longitudinal mixing a gradient
enhanced z-filter was employed using 90° pulses and spoiler gradients of 3 ms total
duration, 500 µs ramp-up/down times, and 11.5 mT/m amplitude, surrounding MLEV-16
block. Due to z-filter, the mixing time does not contribute to the echo time. TOCSY mixing
time was set to 64 ms (Nmix = 2) for phantom experiments at 3T, and to 32 ms (Nmix = 1)
for human volunteer measurements at 1.5T. All 90° pulses used in TOCSY or COSY were
non-selective BIR-4 (46) adiabatic pulses (4 ms duration, 10 kHz bandwidth).
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Selection of coherence transfer pathway (CTP) was performed with sine-bell shaped
gradients of 1 ms duration and 11.5 mT/m amplitude. Phase sensitive spectra can be
obtained with an echo-antiecho acquisition by changing the polarity of the CTP gradients in
separate t1 increments, and in the case of TOCSY the phase of the first 90° z-filter pulse is
simultaneously alternated x to −x (47).
No outer volume suppression (OVS) was necessary on phantoms or human subjects due to
precise LASER pre-localization (35). Water suppression was realized with a WET scheme
(48) in all sequences.
For 2D spectra, the time interval after the first 90° excitation pulse was incremented in
consecutive experiments to realize t1 evolution. A time increment of 0.833 ms was used,
corresponding to approximately 10 ppm (SW of 1.2 kHz at 3T) for f1 (indirect) frequency
dimension, and 64 t1 increments were recorded in four-dimensional (kx,ky,t1,t2) space.
While all sequences are single shot and can be run as such, a minimum phase cycle of two
steps for the first 90° excitation pulse improves spectra quality by removing axial peaks and
t1 noise coming from water signal that starts to recover during t1 evolution. Since averaging
for SNR is typical, a minimum phase cycle is not a problem, and 4 averages were added for
in-vivo experiments. Eight dummy scans were used only before the first t1 increment, to
allow for T1 relaxation and reach a steady-state magnetization.
Spiral waveforms (Nspirals = 380) were played on the read and phase gradient channels for
spectroscopic imaging of LASER pre-localized VOI. Spectral bandwidth for f2 (direct)
frequency dimension was set to 1.2 kHz (Δt2 of 0.833 ms), which roughly corresponds to 10
ppm at 3T. Two CCSI spatial resolutions were tested: 1) field of view (FOV) 16×16 cm2,
8×8 in-plane resolution matrix, 2×2 cm2 in-plane voxel size; 2) FOV 16×16 cm2, 16×16 in-
plane resolution matrix, 1×1 cm2 in-plane voxel size. In all cases a 2.5 cm slice thickness
has been used. Constant-density spiral-out trajectories were designed (49) so that the number
of interleaves was: i) Ninterleaves = 2 for 8×8 matrix (Na = 1, Nt = 2), and ii) Ninterleaves = 6
for 16×16 matrix (Na = 3, Nt = 2). An acquisition time of 8:32 min can be achieved when
recording 64 t1 increments with 4 averages (NA) for 8×8 matrix, and 12:48 min when
recording 64 t1 increments with 2 averages for 16×16 matrix, assuming a repetition time
(TR) of 1s. Spiral trajectories are more time efficient than multiple spin-echoes or EPI. By
comparison, for a slice of 8×8 matrix of voxels the spiral encoded CCSI can be 8 times
faster than multi echo (employing four spin echoes) and 4 times faster than EPI encoded
versions (assuming the same repetition times, number of averages, and t1 increments). In
addition, spiral gradient waveforms have a smoother variation and are less demanding than
EPI for gradient hardware in terms of maximum amplitude, rise time and slew rate.
The maximum gradient and slew rate used in spirals’ design were set to conservative levels,
9.8 mT/m and 120 mT/m/ms, respectively, in order to avoid any kind of gradient fidelity
issues. The length of rewinder gradient was not more than 15% of the total duration of the
spiral lobe. Gradient delays between ADC and x and y gradients were measured to be 8µs,
and were corrected for in the reconstruction.
3.3. CCSI of phantoms
Three phantoms were used to test localization and SNR: i) a large homogenous phantom (16
cm diameter) containing only brain metabolites at physiological concentrations for NAA 8
mM, glutamate (Glu) 6 mM, GABA 1 mM, choline (Cho) 5 mM, creatine (Cre) 3 mM,
myoinositol (Myo) 4mM, and lactate (Lac) 1 mM; ii) a double-layer phantom consisting of
an outer layer (2 cm thick) of oil and an inner core (8 cm diameter) of brain metabolites (the
same like in phantom 1); iii) a phantom with two compartments (6 cm diameter each),
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containing one compartment filled with GABA solution (5 mM) and the other compartment
with lactate solution (50 mM).
CCSI employing COSY-LASER-SPIRAL and TOCSY-LASER-SPIRAL sequences were
performed on all three phantoms at 3T. For each sequence, both 8×8 (Ninterleaves = 2, NA=4)
and 16×16 (Ninterleaves = 6, NA=2) matrix were tested to acquire FOV = 16×16 cm2 and SW
= 1.2 kHz. A TR of 1s was used for COSY-LASER-SPIRAL. Due to higher SAR, a TR of
1.75s was employed for TOCSY-LASER-SPIRAL.
3.4. CCSI of human subjects
CCSI of human brain was collected on six healthy volunteers (30 years median age) and
three patients with brain tumor (Glioblastoma multiforme, GBM, 45 years median age). The
studies with human subjects were approved by the IRB of our institution.
A minimum TR of 1s with COSY-LASER-SPIRAL was possible on all human subjects at
3T. Because of higher SAR, a minimum TR in the range of 2s–3s would be necessary for
TOCSY-LASER-SPIRAL on human subjects at 3T (20). Because of slower buildup curves,
longer TR and longer associated scan times at 3T for TOCSY-LASER-SPIRAL, only
COSY-LASER-SPIRAL sequence was tested in vivo at 3T. TOCSY-LASER-SPIRAL was
demonstrated on human volunteers at 1.5T where faster buildups provide increased
crosspeaks for shorter mixing times and SAR constrains allows a TR of 1.5s or shorter. A
total acquisition time of less than 10 minutes was considered as desirable for human CCSI,
and this can be achieved at 3T with COSY-LASER-SPIRAL that acquires a 8×8 matrix
(Ninterleaves = 2), 64 t1 increments, NA = 4, and TR = 1s in a total time of 8:32 min. The
same matrix was used for TOCSY-LASER-SPIRAL on human volunteers at 1.5T, but
acquiring 50 t1 increments, NA = 12 and TR = 1.5s in 30 min. The TOCSY mixing time
was set at 32ms for measurements on human subjects at 1.5T. The RF amplifiers of the
Avanto systems drain for mixing times longer than 32 ms and trigger an execution error,
while RF amplifiers of 3T Tim Trio allow mixing times of up to 100 ms. As shown in
simulations TOCSY buildups are faster at 1.5T, and 32 ms mixing yield detectable
crosspeaks for most metabolites. In all experiments FOV of 16×16 cm2 and a slice thickness
of 2.5 cm were chosen, yielding voxels of 10 ml (2×2 cm2 in-plane resolution) which was
found to be the minimum voxel volume for adequate SNR of COSY with acquisition times
shorter than 10 min.
Images used to position VOI of CCSI were acquired with: i) MEMPRAGE (50) sequence
(TR = 2.53 s, TE1/TE2/TE2/TE3/TE4 = 1.64/3.5/5.36/7.22 ms, TI = 1.2 s, 1 mm3 isotropic)
for volunteers; ii) MEMPRAGE acquired post-Gd (Magnevist) contrast i.v. injection in
tumor patients. B0 shimming over the entire VOI was performed using the Siemens
advanced shimming routine until a line width of 15 Hz (magnitude mode) or better was
obtained for the water signal.
3.5. Processing of the CCSI data
Spiral data from separate receive coils were 2D gridded on a Cartesian grid for FFT (Fast
Fourier Transformation) using Kaiser-Bessel kernel (51), and the data from all 32 coil
elements were combined using complex coil weights obtained from a short prescan. No
window function was applied for k-space. Data were zero filled to 512 points in the t2
dimension prior to FFT. For each t1 increment (all 64 (kx,ky,t2) sub-spaces) reconstruction
along spatial (x,y) and f2 frequency dimension was implemented in the Siemens Image
Calculation Environment (ICE), and viewing of the reconstructed 1D spectra was therefore
possible online at the Siemens scanner console. The grid of 1D spectra corresponding to the
first t1 increment was always inspected for quality assurance. All t1 increments acquired on
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the 8×8 matrix were interpolated to 16×16 matrix by the on-line ICE reconstruction
program. However, 2D spectra analysis was performed on the original 8×8 acquisition
matrix by summing the signal of each 4 neighboring voxels. The matrix of 16×16 data was
not modified, and was kept the same for 1D and 2D reconstruction.
Reconstruction along f1 frequency dimension was performed off-line in Matlab. The
DICOM files of each t1 increment were exported off-line and loaded into Matlab for FT
along f1 frequency dimension. Due to heavy signal truncation along t1 dimension, linear
prediction is mandatory prior to FT in order to reduce large ringing ridges along f1 spectral
dimension. Linear prediction forward to 128 points along f1 using the ITMPM method
(Information Theory and the Matrix Pencil Method, (52)) has been employed. A shifted
square-sine window function was employed in both f1 and f2 dimensions in order to improve
crosspeaks, reduce ringing and baseline distortion. The 2D spectra were displayed as
contour levels in magnitude mode, with the first contour level chosen three times floor noise
level as estimated from standard deviation of baseline in a signal free spectral region
(0.5ppm-0ppm/0.5ppm-0ppm).
4. RESULTS
4.1. Simulations
Simulated buildup curves for crosspeaks of TOCSY and COSY experiments at 3T and 1.5T
are shown in Figure 2. In general, as mentioned in the theory part, lower RF fields provide
slower TOCSY buildups. Ideal TOCSY buildup curves can be obtained for RF amplitudes
above threshold values of 1.5 kHz at 3T and 1.1 kHz at 1.5T, which are slightly larger than
the 1 kHz maximum RF amplitude deliverable by the body transmit coil. In the case of
TOCSY at 3T (Fig. 2A), longitudinal mixing with B1,max = 0.75 kHz exhibits a buildup rate
which is half of the ideal buildup rate obtained if only scalar coupling is considered.
Approximately 50% transfer can be obtained for a mixing time of 64 ms. An increase to the
maximum available RF amplitude (B1,max = 1 kHz) provides a significantly faster buildup,
improving transfer efficiency to approximately 80% at 64 ms mixing time. The differences
are explained by the fact that larger RF field amplitudes averages-out more effectively the
unwanted chemical shift interaction in the first order average Hamiltonian, resulting in a
stronger effective scalar coupling constant (Jeff). In experimental testing, efficiency of
mixing at higher RF increased only slightly, which could be related to the fact that the RF
amplifier can not sustain required amplitude for the entire duration of mixing period.
TOCSY buildups at 1.5T (Fig. 2B) are much closer to the ideal buildup, having 90%
efficiency at 64 ms mixing for B1,max = 0.75 kHz, owing to the two-fold reduction of
chemical shift interaction. Mixing 32 ms at 1.5T provides similar efficiency as mixing 64 ms
at 3T using B1,max = 0.75 kHz in the case of the two spin system of lactate. Performing
TOCSY experiment at 1.5T with 32 ms time mixing has the advantage of a decreased SAR
deposition.
COSY buildups were simulated for the same spin system at 3T (Fig. 2C) and 1.5T (Fig. 2D).
The situation when only scalar coupling is considered provides the same buildup as in the
case of TOCSY. When chemical shifts are included, fast oscillations superimpose on the
scalar coupling buildup due to transverse mixing of COSY. However, the maximum transfer
occurs at the same position in all buildups (approx. 64 ms mixing time).
Point spread functions for spirals designed to acquire 8×8 and 16×16 matrixes over FOV =
16×16 cm2 and SW = 1.2 kHz are shown in Figure 3. One angular interleave is necessary for
8×8 matrix (Fig. 3A), while three angular interleaves are used for 16×16 matrix (Fig. 3B).
Good spatial localization is noticed for both matrixes. Although 8×8 matrix represents a
coarse spatial coverage, the associated PSF (Fig. 3C) has a well defined main lobe with a
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full width at half maximum (FWHM) of 2 cm and the baseline ringing does not indicate
considerable voxel bleeding. The ratio between the first positive sidelobe and the main lobe
is 2.6%. Similar results are obtained for PSF of 16×16 matrix (Fig. 3D) that has, as
expected, a two fold narrower main lobe (FWHM = 1 cm). The largest signal contamination
and voxel bleeding could come from subcutaneous lipids, however this possibility is
eliminated by the sharp excitation profile of LASER as shown in Supplementary
Information (Figs. S1 and S2). In-vivo data confirm these findings in both volunteers and
patients.
4.2. Phantom data
Several aspects of CCSI were investigated at 3T on three phantoms: 1) uniformity of
excitation and SNR of 2D MRS in the uniform phantom; 2) LASER pre-localization of VOI
and lipid contamination in the double-layer phantom; 3) spatial encoding of spiral
trajectories in the two-compartment phantom. Experiments on phantoms have been
performed to choose meaningful starting parameters for in-vivo measurements. The results
obtained on the double-layer and the two-compartment phantoms are shown in
Supplementary Information (Figs. S2 and S3).
In Figure 4 results obtained on the uniform phantom containing brain metabolites at
physiological concentrations are shown. A VOI (blue rectangle, 10×10 cm2 in plane, 2.5 cm
thickness) was selected by LASER. Two in plane resolutions of 1×1 cm2 (16×16 matrix,
FOV = 16×16 cm2) and 2×2 cm2 (8×8 matrix, FOV = 16×16 cm2) were tested in order to
investigate the SNR limits and optimize acquisition parameters for in-vivo experiments. We
found that a voxel size of 10 ml (2×2×2.5 cm3) was necessary for adequate SNR if the
acquisition times were to be shorter than 10 minutes. Spectra recorded with both COSY-
LASER-SPIRAL and TOCSY-LASER-SPIRAL sequences are included.
Crosspeaks of all metabolites are well visible and separated from the main diagonal. Due to
coherent transfer of in-phase longitudinal magnetization in TOCSY the multiplet structure of
each crosspeak is more apparent in TOCSY spectra than in COSY. Transfer over multiple
bonds is possible in TOCSY and relay crosspeaks are visible in TOCSY spectra which can
not be obtained in COSY (see also Fig. 3 in Supplementary Information). To illustrate SNR
of 2D MRS, projections along f1 and f2 spectral dimensions are shown for lactate crosspeak.
Due to transfer of in-phase and anti-phase magnetization, partial signal cancellation can be
noticed for COSY as a notch in the middle of the crosspeak along f2 projection, and slightly
larger linewidths for COSY crosspeaks is noticed in both f1 and f2 projections (see also
enlarged crosspeaks in Fig. S4 from Supplementary Information). The expected CH
multiplet structure of Lactate is clearly noticed in the f2 projection from TOCSY. 1D
spectrum of the first t1 increment from the same voxel is included for comparison. A
quantitative analysis is presented in Tables 1 and 2.
4.3. Human data
CCSI measured at 3T on the brain of a healthy volunteer with COSY-LASER-SPIRAL
sequence is shown in Figure 5. Spectra are acquired in 8:32 min, using parameters tested on
the uniform brain phantom. LASER selects a large VOI (8×8 cm2, blue rectangle) in
centrum semiovale above the ventricles, which includes the central 4×4 voxels of FOV
(yellow rectangle). Example of a representative 2D spectrum from a central voxel (red
outlined) shows clear crosspeaks which correspond to NAA, glutamate, GABA, choline,
glycerophosphocholine (GPC), phosphocholine (PC), phosphoethanolamine (PE),
myoinositol, and threonine (Thr). Projections along f1 and f2 spectral dimensions through
glutamate crosspeak are indicative of SNR and quality of data. 1D spectrum of the first t1
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increment from the same voxel is shown for direct visual comparison. Tables 1 and 2
contain the quantitative analysis.
TOCSY-LASER-SPIRAL spectra measured at 1.5T on a healthy volunteer are shown in
Figure 6. The size and position of FOV (yellow rectangle) and VOI (blue rectangle) were
chosen the same like for COSY volunteer. Crosspeaks corresponding to aspartate (Asp),
NAA, glutamate, choline, myoinositol, and threonine are clearly seen. Crosspeaks of GPC,
PC, PE were not detected, presumably due to shorter 32 ms mixing time. In a previous (20)
single voxel implementation of TOCSY at 3T the crosspeaks of GPC were observed for 64
ms mixing time. f1 and f2 projections through glutamate crosspeak, and 1D spectrum of the
first t1 increment show the quality (SNR, baseline) of data. For all metabolites, crosspeaks
are well above noise level, and the quantitative estimation is presented in Tables 1 and 2.
Figure 7 demonstrates results obtained at 3T from a patient with glioblastoma. The same
acquisition parameters as in the volunteer case are used to acquire COSY-LASER-SPIRAL
spectra. The two tumor regions visible in contrast enhanced T1 weighted image can be
identified also in 2D spectra. Characteristic for the tumor regions are large lipid (Lip) signals
suggestive of underlying necrosis. However, the high lipid signals do not contaminate
visibly the neighboring voxels through PSF ringing.
An overlay of 2D COSY spectra originating in a tumor region (red spectrum) and in a
healthier region (blue spectrum) is shown. The tumor spectrum represents a good example
of COSY being able to resolve overlapping metabolite signals such as lipids and lactate. In
the corresponding 1D spectrum shown below, lipid and lactate signals overlap completely.
Interestingly, while NAA is absent as expected, aspartate signal is detected in tumor by in-
vivo 2D MRS, which could be related to tumor biology. This is in line with our previous
findings (53) from high quality ex-vivo 2D high resolution magic-angle-spinning (HRMAS)
spectra of intact glioblastoma biopsies. Choline, GPC, PE and myoinositol are identified in
the tumor spectrum, though they do not seem to be enhanced compared to the healthy
spectrum. This is evident also by comparing the total choline peak in the 1D spectra. A
distinct crosspeak (X) seems to be present at 3.6/2.3 ppm (f2/f1) in the tumor spectrum
which could match the Hα-Hβ correlation for valine. However, this assignment can be made
only tentatively since the Hβ-Hγ correlations of valine are not seen. The high signal at ~0.9
ppm in the methyl region of the 1D spectrum could be suggestive of contribution from
metabolites containing methyl groups such as valine.
4.4. Quantitative analysis
Quantitative analysis of SNR is provided in Table 1 for each sequence in phantoms and
volunteers. In phantoms SNR of crosspeaks is greater than 20 for all metabolites. In
volunteers the minimum SNR of COSY crosspeaks at 3T is approximately 10, while the
minimum SNR of TOCSY crosspeaks at 1.5T is 8. The SNR of crosspeaks relative to the
SNR of diagonal peaks is indicative of the sensitivity of the 2D MRS compared to the 1D
MRS. The largest difference is observed for NAA and Cho, which is explained by the fact
that considerable more protons contribute to the main diagonal peaks of NAA (2.01 ppm)
and Cho (3.19 ppm) compared to their crosspeaks, NAA (4.38/2.67 ppm) and Cho (4.05/3.5
ppm). For other metabolites that do not have uncoupled methyl groups giving rise to intense
singlet diagonal peaks, the SNR of crosspeaks compares more favorably to the SNR of
diagonal peaks, ranging between 13% and 70%. In general SNR of TOCSY compared to
SNR of COSY is lower (47% to 77% in phantoms), with the exception of lactate which has
a better SNR in TOCSY.
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Volumes of individual crosspeaks and diagonal peaks are given in Table 2. Concentration of
each metabolite can be estimated from the volumes of the corresponding crosspeaks and a
calibrated reference signal. Comparison between volumes of crosspeaks and diagonal peaks
needs to take into account the number of protons contributing to the formation of crosspeak
or diagonal peak, the mixing time, and the buildup rate of crosspeaks. With these
corrections, similar metabolite ratios are found when using crosspeak volumes or diagonal
peak volumes. For in-vivo 2D MRS quantification, often the ratio of the metabolite
crosspeak volume to the creatine diagonal peak volume is reported (9), and the volume of
diagonal peak of creatine is included in Table 2.
5. DISCUSSIONS
In-vivo 2D-spectral/2D-spatial MRS has tremendous potential to improve our ability to
characterize metabolism under normal physiological and disease conditions by disentangling
overlapped spectra or uncovering new metabolites that are typically obscured in one-
dimensional spectroscopy. However, this method faces difficult challenges related to limited
spatial coverage and long acquisition times. In this work we extended correlation MRS to an
imaging modality and show that this can be realized in-vivo within feasible scan times.
Combining optimized adiabatic excitation and spiral encoding we demonstrated the concept
of correlation chemical shift imaging (CCSI). Two CCSI methods are introduced based on
COSY and TOCSY, respectively. Although multivoxel COSY has been proposed previously
(11–17), this work represents the first thorough demonstration of a robust and practical in-
vivo CCSI which includes clinical applications of COSY based CCSI. Importantly, the
TOCSY based CCSI is demonstrated for the first time.
Compared to COSY, TOCSY has the advantage of eliminating signal cancellation and
improving spectral resolution with pure absorptive phase-sensitive crosspeaks obtained
through coherent transfer of in-phase longitudinal magnetization (20). TOCSY provides also
the entire set of correlations necessary for assignment, which could potentially help if
ambiguities still exist in the COSY spectra. On the other hand, COSY spectra have a higher
SNR than TOCSY because the optimum mixing conditions for TOCSY are harder to realize
in-vivo within SAR limits. A TOCSY transfer efficiency of 50% has been obtained in single
voxel in-vivo experiments at 3T for 64ms mixing with GOIA-W(16,4) pulses of 0.75 kHz
amplitude (20). In addition, fully adiabatic TOCSY needs longer scanning times associated
with longer repetition times. Hence, for in-vivo studies on human subjects presented in this
work it was considered that COSY based CCSI represents a more feasible choice at 3T.
Using COSY-LASER-SPIRAL sequence it was found that a matrix of 8×8 voxels (each 10
ml) can be recorded in-vivo at 3T with adequate SNR in 8:32 min. TOCSY-LASER-
SPIRAL was demonstrated in healthy volunteers at 1.5T using similar matrix and voxels. 2D
MRS at low magnetic fields could be useful to resolve larger metabolite overlap in 1D MRS
due to reduced chemical shift dispersion. This can be relevant, since many clinical scanners
operate in the range of 1.5T to 3T. In cases where SAR is less strict (phantoms, animal
studies, other organs than brain) or when the acquisition time is not limited, TOCSY based
CCSI may of course be a good option at 3T. An alternative at 3T, may be CCSI based on
semi-adiabatic TOCSY (20), which would have a lower SAR and shorter repetition times.
However PRESS or STEAM localization used in semi-adiabatic TOCSY will be affected by
CSDE and will require optimized OVS (54,55) to reduce lipid contamination. Standard OVS
saturation bands existing on clinical scanners do not provide adequate fat suppression for in-
vivo CSI using PRESS or STEAM selection of VOI, as shown in Ref. (20). We intend to
investigate this possibility in a future work.
A key step in the feasibility of this approach is constant-density spiral encoding which is
highly time efficient. For an 8×8 matrix the minimum acquisition is 2s, becoming favorable
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for dynamic spectroscopy. Further acceleration can be obtained with parallel spectroscopic
imaging (56), and combining sparse k-space sampling with spiral encoding (28,57). Speed-
up of 2D spectra acquisition can be also obtained by sparse sampling of t1 dimension (58).
For the same purpose, the method of ultra-fast single scan acquisition of multidimensional
NMR spectra (59) could be adopted with suitable modification. Constant time evolution
(31,60) could be employed in order to reduce the number of t1 increments. The number of
averages and of t1 increments can be traded for more SNR, or for better resolution along f1,
depending on the limiting factor.
A minimum SNR of 10 was found in-vivo for COSY, while in-vivo TOCSY had a slightly
lower minimum SNR of 8. The SNR could be increased with out-and-in spirals (61) or other
self rewinding trajectories that can eliminate signal losses during the rewinder gradient.
Optimal combination of MRS signal from multiple coils (62) by phase and baseline
correcting the signal of each coil before their combination could increase sensitivity.
Furthermore, SNR of 2D MRS can be improved if the signal of both crosspeaks is
combined.
The 8×8 matrix (2×2 cm2 in-plane spatial resolution) is sufficient in the human brain to
separate regions with disease, such as tumors, from regions with healthier tissue. Point
spread function simulations indicate that signal contamination due to ringing of the impulse
function would not produce considerable signal contamination at this low resolution matrix.
Voxel bleeding was not noticed in human subjects, though some voxel bleeding was
observed in phantoms at high concentrations (lactate 50 mM, Fig. 3 in Supplementary
Information). If necessary, application of a Hanning or Hamming window in the k-space can
reduce ringing of point spread function, at the cost of altering in-plane voxel size. Extension
to 3D spatial coverage of CCSI could be attempted by adding phase encoding along kz
direction as was shown for J-resolved spectra (30). A 3D matrix of 8×8×4 could be acquired
in 8:32 min, if averaging is traded for phase encoding.
Adiabatic excitation with very large BW (20 kHz) pulses used in this work minimize
chemical shift displacement error and provide optimal flip angles uniformly across large
VOI and SW even in the presence of inhomogeneous RF fields. These features could be of
interest also at high field (7T). The precise LASER localization provides artifact-free
spectra. If optimal OVS (54,55) is available, a single spin-echo based slice selection that
includes all the brain can be easily considered with GOIA-W(16,4) pulses. The low SAR of
GOIA-W(16,4) enables repetition times that keep total scan time within feasible limits.
The in-vivo cases illustrate the potential of CCSI to resolve overlapped metabolites such as
the total choline peak, GABA, glutamate, and threonine in normal subjects, or lactate and
lipids in cancer. In disease CCSI could perhaps help to identify other important metabolites
such as aspartate in the case of the tumor patient. Although aspartate and N-acetyl-aspartate
are related metabolites they have different distribution in brain. While NAA is specific to
neurons, aspartate can be synthesized both in astrocytes and neurons reversibly via
transamination, and it can be transferred between the two cell types in both directions (63).
Importantly, only astrocytes were shown to express the enzymes for de novo pyrimidine
biosynthesis (64), and aspartate is one of the few substrates required for de novo pyrimidine
synthesis. This could be relevant for tumors where nucleotides would be necessary for DNA
during high mitotic activity of cancer cells. Since tumor cells in glioblastoma have an
astrocytic origin it is likely that these tumors might contain increased levels of aspartate.
This possibility is supported also by our previous work (4,53) with ex-vivo high quality 2D
HRMAS that detects high aspartate in intact biopsies from glioblastoma patients. Although
neuro-glial metabolism has been largely investigated in normal cell cells cultures or animals,
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there are less data in the literature from in-vivo studies of human brain tumors related to
aspartate. The significance of our findings remains to be investigated in more detail.
Compared to 1D spectral editing methods that filter out most of the metabolites in order to
detect one metabolite of interest, 2D methods retain the full spectral information. In
addition, the first t1 increment of the CCSI experiments is available for analysis with the
established methods (eg. LCModel, (65)) of conventional CSI. Nevertheless, more
automated analysis (Profit, (66)) methods exist also for in-vivo 2D MRS.
Absolute quantification of in-vivo 2D MRS spectra could be done using ERETIC method
(67), which would yield more precise results especially in disease than metabolite crosspeak
to creatine diagonal peak volume ratio.
While these initial results are promising, in-vivo multi-spectral-spatial-dimensional MRS is a
field that needs further development and validation. Advances in sequence design such as
presented herein, reconstruction algorithms, and hardware development might improve the
performance of 2D MRS through increased signal to noise ratio, better spatial resolution or
shortened acquisition time. Future development could facilitate in-vivo biomedical
applications of 2D MRS methods and further our knowledge of normal metabolism and
disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ADC Analog to Digital Converter
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AHT Average Hamiltonian Theory
Asp Aspartate
BW Bandwidth
Cho Choline
CSI Chemical Shift Imaging
CCSI Correlation Chemical Shift Imaging
COSY Correlation Spectroscopy
CT-COSY Constant Time COSY
CSDE Chemichal Shift Displacement Error
EPI Echo Planar Imaging
f1, f2 Indirect and direct detected frequency dimensions
FOV Field Of View
FWHM Full Width at Half Maximum
GABA Gamma-amino-butyric acid
GBM Glioblastoma
Glu Glutamate
GOIA Gradient Offset Independent Adiabaticity
GPC Glycero-phospho-choline
HRMAS High Resolution Magic Angle Spinning
LASER Localizer Adiabatic Spin Echo Refocusing
Lac Lactate
L-COSY Localized COSY
MLEV-16 Malcolm Levitt's composite decoupling sequence
MRS Magnetic Resonance Spectroscopy
Myo Myoinositol
NA Number of Averages
NAA N-acetyl-aspartate
OVS Outer Volume Suppresion
PC Phospho-choline
PE Phospho-ethanolamine
PEPSI Proton Echo Planar Spectroscopic Imaging
PRESS Point Resolved Spectroscopy
PSF Point Spread Function
RF Radio Frequency
SAR Specific Absorption Rate
SNR Signal to Noise Ratio
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STEAM Stimulated Echo Amplitude Modulated
SW Spectral Bandwidth
TE Echo Time
TR Repetition Time
tmix, t1, t2 mixing time, evolution time, detection time
TOCSY Total Correlation Spectroscopy
Thr Threonine
VOI Volume Of Interest
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Figure 1.
CCSI pulse sequences for 2D-spectral/2D-spatial TOCSY-LASER-SPIRAL and COSY-
LASER-SPIRAL experiments. LASER and GOIA-W(16,4) adiabatic pulses are used to
select the desired VOI in both sequences (TE = 40ms). A gradient enhanced z-filter,
composed of 90° adiabatic BIR-4 pulses and spoilers brackets the MLEV-16 block (pulses
which are grayed-out have an overall 180° phase shift compared to non-grayed pulses, 64
ms total mixing time, Nmix = 2) to perform longitudinal mixing in TOCSY. Sine-bell shaped
gradients select the coherence transfer pathway. Phase sensitive 2D spectra can be obtained
with echo-antiecho acquisition if the polarity of gradients is alternated and the FID are
stored separately, and for TOCSY the phase of the first 90° pulse of the z-filter is
simultaneously alternated x to −x. The delay after the first 90° BIR-4 excitation pulse is
incremented in consecutive experiments in order to encode the f1 frequency dimension. The
t1 increment is inversely proportional to the desired spectral bandwidth in the f1 frequency
dimension. To eliminate the t1 noise and improve water suppression in 2D spectra, a two
step phase cycle is used, involving the first excitation pulse and the receiver. Spiral
waveforms are played on the phase and readout gradients to acquire simultaneously two
spatial dimensions and one frequency dimension (rewinding gradients for each spiral lobe
are shown in black). The duration of a spiral lobe is inversely proportional to the desired
spectral bandwidth (SW) in the f2 frequency dimension. The spiral lobes are repeated
(Nspirals = 380) within one acquisition window in order to encode the f2 frequency
dimension. The desired FOV, in-plane spatial resolution and SW are obtained by temporal
and angular spiral interleaves (Ninterleaves = 2 for 8×8 matrix, and Ninterleaves = 6 for 16×16
matrix). The WET water suppression is not included in the pulse sequence diagrams. No
OVS is necessary with LASER localization.
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Figure 2.
Simulated buildup curves of crosspeaks for TOCSY and COSY at 3T and 1.5T in the case of
a two spin system having the scalar coupling and chemical shifts of lactate. Ideal buildup
curves obtained when only the scalar coupling is considered are shown in black.
Longitudinal TOCSY mixing with MLEV-16 (Fig. 2A,B) is considered for two GOIA-
W(16,4) pulses with a lower B1,max amplitude (0.75 kHz, blue line) and a higher B1,max
amplitude (1 kHz, red line). Slower buildups are noticed for the lower B1,max field,
corresponding to a weaker average Hamiltonian and a smaller effective scalar coupling.
Transverse mixing for COSY results in rapid oscillations (red line, Fig. 2C,D) when
chemical shifts are included, modulated by the slower scalar coupling buildup.
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Figure 3.
Point spread function simulations for the 8×8 and 16×16 matrixes used for CCSI. The spiral
trajectories designed to acquire the FOV = 16×16 cm2 are shown for the 8×8 matrix (Fig.
3A, one angular interleave) and 16×16 matrix (Fig. 3B, three angular interleaves). Two
temporal interleaves are necessary for SW = 1.2 kHz, obtained by delaying with 1/SW the
angular interleaves in consecutive repetitions. PSF has a well defined main lobe with
FWHM = 2 cm for 8×8 matrix, and FWHM = 1 cm for 16×16 matrix. The ringing of
baseline does not indicate considerable voxel bleeding for any matrix, the ratio between the
first positive sidelobe and the main lobe is 2.6% for 8×8 matrix, and 2.7% for 16×16 matrix.
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Figure 4.
CCSI at 3T in a homogeneous phantom containing brain metabolites at physiological
concentrations. A large VOI (10×10 cm2, slice thickness 2.5 cm, blue rectangle) is selected
by LASER and imaged with spiral encoding (FOV = 16 × 16 cm2 yellow rectangle, 8×8
acquisition matrix, Ninterleaves = 2, 2×2 cm2 in-plane resolution, 10 ml voxel volume). Other
acquisition parameters: 1) COSY – NA = 4, 64 t1 increments, TR = 1s, 8:32 min acquisition
time; 2) TOCSY – NA = 4, 64 t1 increments, TR = 1.75s, 14:56 min acquisition time. The
1D spectral grids of each t1 increment are interpolated to a 16×16 matrix (green grid) by the
on-line ICE reconstruction program, however for 2D spectral analysis the spectra are
reconstructed off-line on the acquired 8×8 matrix. Linear prediction to 128 points in t1 using
ITMPM method (Ref. (52)) and a shifted sine-squared window are applied in both t1 and t2
dimensions before FT. Crosspeaks can be assigned for all metabolites NAA, choline (Cho),
glutamate (Glu), GABA, lactate (Lac), myoinositol (Myo). All the voxels within VOI, and
an enlarged central voxel (red encircled) are shown. Note that narrower crosspeaks are
obtained in the TOCSY spectra due to coherent transfer of in-phase longitudinal
magnetization. An overlay between COSY (red) and TOCSY (blue) spectra from the central
voxel is shown, the arrowheads indicate relay crosspeaks in TOCSY. Similar contour levels
are displayed in COSY and TOCSY spectra. f1 and f2 projections through the lactate
crosspeak show very good SNR (asterisk indicates the crosspeak, the other peak corresponds
Andronesi et al. Page 23
NMR Biomed. Author manuscript; available in PMC 2013 February 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
to the diagonal peak). For COSY partial signal cancellation can be noticed as a notch in
lactate crosspeak along f2 projection, and slightly larger linewidths along both f1 and f2
projections (see also Fig. S4 in Supplementary Information). 1D spectra from the first t1
increment of COSY and TOCSY are shown for comparison.
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Figure 5.
CCSI acquired at 3T in 8:32 min using COSY-LASER-SPIRAL in a healthy volunteer. A
VOI (8×8 cm2, 2.5cm slice thickness, blue rectangle) is selected by LASER in centrum
semiovale above the ventricles (no OVS was used around the skull). The same acquisition
parameters and processing methods as in Fig. 4 were employed. The 4×4 voxels (each 10
ml) inside the VOI are shown together with an enlarged spectrum from a central voxel (red
outlined). Crosspeaks of several metabolites can be clearly identified: NAA, Cho, Glu,
GABA, Myo, GPC (Glycerophosphocholine), PC (Phosphocholine), PE
(Phosphoethanolamine), and Threonine (Thr). In particular, resolving the total choline peak
(Cho, GPC, PC) and GABA peak can be realized. f1 and f2 projections through the
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glutamate crosspeak indicate the quality of 2D spectra (SNR and baseline). 1D spectrum
from the first t1 increment is shown for comparison.
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Figure 6.
CCSI acquired at 1.5T in 30 min using TOCSY-LASER-SPIRAL in a healthy volunteer.
FOV of 16×16 cm2, matrix 8×8, NA = 12, 50 t1 increments, TR = 1.5s and 32 ms TOCSY
mixing time were used. A VOI (8×8 cm2, 2.5cm slice thickness, blue rectangle) is selected
by LASER in centrum semiovale above the ventricles (no OVS was used around the skull).
The same processing methods like in Fig. 4 and 5 were employed. The 4×4 voxels (each 10
ml) inside the VOI are shown together with an enlarged spectrum from a central voxel (red
outlined). Crosspeaks of several metabolites can be clearly identified: Aspartate (Asp),
NAA, Cho, Glu, Myo, and Thr. Crosspeaks of GPC, PC, PE were not detected presumably
due to shorter mixing time. f1 and f2 projections through the glutamate crosspeak indicate
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the quality of 2D spectra (SNR and baseline). 1D spectrum from the first t1 increment is
shown for comparison.
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Figure 7.
CCSI acquired at 3T in 8:32 min using COSY-LASER-SPIRAL in a patient with a
glioblastoma. A VOI (8×8 cm2, 2.5cm slice thickness, white rectangle) is selected by
LASER on the post contrast MEMPRAGE image to include both tumor foci (no OVS was
used around the skull). The same acquisition parameters and processing methods as in Figs.
4 and 5 were employed. All the 4×4 voxels (each 10 ml) inside the VOI are shown. The
dashed white lines on the MEMPRAGE image indicate the grid of the 4×4 voxels. It can be
noticed that the 2×2 cm2 in-plane spatial resolution of the 2D spectra can discriminate the
tumor distribution. An overlay between a tumor spectrum (sum of voxels outlined by red
line) and a spectrum from a healthier region (sum of voxels outlined by blue line) is shown.
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In the tumor spectrum lactate (Lac) and lipid (Lip) signals are clearly separated. By
comparison in the 1D spectra originating from the same voxels shown bellow, the lactate
and lipid overlap completely. Choline, GPC and PE do not seem to be enhanced in the
tumor, as indicated also by the total choline peak of the 1D spectra. Aspartate (Asp) signal is
detected in tumor which can be biologically relevant for tumor metabolism. A distinct
crosspeak X seems to be present at 3.6/2.3 ppm (f2/f1) in the tumor spectrum which could
match the Hα-Hβ correlation of valine, although this assignment can be made only
tentatively.
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